참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Hydrochloric Acid | HCID 313 | — |
| 반응물 | 5-Bromopyrimidine | HCID 78344 | — |
| 반응물 | Pyrrolizinium, 1,2,3,5,6,7-hexahydro-, perchlorate | HCID 10878400 | — |
| 반응물 | HCID 178418306 | HCID 178418306 | — |
| 용매 | Diethyl Ether | HCID 3283 | — |
| 용매 | Pentane | HCID 8003 | — |
| 용매 | Ether tetrahydrofuran | HCID 21868444 | — |
| 생성물 | 7a-(5-Pyrimidinyl)-hexahydro-1h-pyrrolizine | HCID 18934768 | 18% |
반응 단계
A solution of 1.7M tBuLi (1.6 mL, 2.6 mmol) in pentane was added to 5-bromopyrimidine (190 mg, 1.2 mmol) in Et2O:THF (1:1, 12 mL) at -100° C. After stirring for 10 minutes, 1,2,3,5,6,7-hexahydropyrrolizinium perchlorate (500 mg, 2.4 mmol) was added to the reaction slurry, and stirring was continued for 30 minutes. The reaction mixture was then allowed to warm to 0° C. and stir for 1 hour. A solution of 2N HCl was added, and the reaction mixture was poured over Et2O and the phases separated. The aqueous phase was basified with 15% NaOH solution and extracted with CH2Cl2 (2×). The CH2Cl2 phases were combined, dried (MgSO4), concentrated, and the residue was chromatographed (silica gel; CHCl3 /MeOH, 98:2) to afford a clear oil (40 mg, 18%). MS (CI/NH3) m/e: 190 (M+H)+. 1H NMR (CDCl3, 300 MHz) δ1.60-1.73 (m, 2H), 1.82-2.11 (m, 6H), 2.66-2.75 (m, 2H), 3.15-3.21 (m, 2H), 8.85 (s, 2H), 9.05 (s,1H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05733912 |
|---|
| 출처 데이터셋 | uspto-grants-1998_03 |
|---|
| ORD ID | ord-00d6327228e6450289cc61943cc4bea5 |
|---|
| 출처 메모 | uspto-grants-1998_03 |
|---|